Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000899243-02-000797
Filing Date
2002-03-27
Accepted
2002-03-27 00:00:00
Documents
9
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.txt 10-K 195130
3 BY-LAWS dex36.txt EX-3.6 51396
4 AMENDED AND RESTATED CONSULTING AGREEMENT W/MICHAEL A. ZASLOFF dex105.txt EX-10.5 21684
5 EMPLOYMENT AGREEMENT - MICHAEL E. PETRONE, M.D. dex1010.txt EX-10.10 3587
6 LEASE AGREEMENT dex1012.txt EX-10.12 131627
7 RENEWAL OF LICR RESEARCH AGREEMENT dex1022.txt EX-10.22 3469
8 AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT W/MEDIMMUNE dex1025.txt EX-10.25 2480
9 LADENBURG THALMANN WARRANTS dex1027.txt EX-10.27 60052
10 INDEPENDENT ACCOUNTANTS' CONSENT dex231.txt EX-23.1 1083
  Complete submission text file 0000899243-02-000797.txt   473135
Mailing Address 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Business Address 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 6109415231
GENAERA CORP (Filer) CIK: 0000880431 (see all company filings)

EIN.: 133445668 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19651 | Film No.: 02589204
SIC: 2836 Biological Products, (No Diagnostic Substances)